Showing results (61-70 of 160) with videos related to
Sort By:
Pageof 16
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1972
Inactivator of the third component of complement as an inhibitor in the properdin pathwayC A Alper, F S Rosen, P J LachmannLancet (London, England)|June 9, 1979
Genetic marker for insulin-dependent diabetes mellitusD Raum, C A Alper, R Stein, et al.The Journal of Allergy and Clinical Immunology|February 1, 1986
The metabolism of C1 inhibitor and C1q in patients with acquired C1-inhibitor deficiencyJ Melamed, C A Alper, M Cicardi, et al.Immunogenetics|March 31, 2012
Genetic polymorphism of serum complement components in the chimpanzeeD Raum, H Balner, B H Petersen, et al.Clinics in Haematology|October 1, 1983
The MHC in human bone marrow allotransplantationE J Yunis, Z Awdeh, D Raum, et al.Biochemical Society Symposium|January 1, 1986
Complement genes of the major histocompatibility complex (complotypes), extended haplotypes and disease markersC A Alper, Z Awdeh, D Raum, et al.Experimental and Clinical Immunogenetics|July 19, 2000
A simple estimate of the general population frequency of the MHC susceptibility gene for autoimmune polygenic diseaseC A Alper, D P Dubey, E J Yunis, et al.The Journal of Experimental Medicine|April 1, 1978
Acute phase reactants ceruloplasmin and haptoglobin and their relationship to plasma prostaglandins in rabbits bearing the VS2 carcinomaE F Voelkel, L Levine, C A Alper, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1977
Complement activation in semisolid media: insolubilization of alternative pathway convertases in agar gels with C3 nephritic factor-containing seraM A Arnaout, A E Davis, R S Rosen, et al.Science (New York, N.Y.)|August 6, 1971
C1 inhibitor: evidence for decreased hepatic synthesis in hereditary angioneurotic edemaA M Johnson, C A Alper, F S Rosen, et al.Pageof 16